Romergryko G Geocadin1, Eelco Wijdicks1, Melissa J Armstrong1, Maxwell Damian1, Stephan A Mayer1, Joseph P Ornato1, Alejandro Rabinstein1, José I Suarez1, Michel T Torbey1, Richard M Dubinsky1, Jason Lazarou1. 1. From the Departments of Neurology, Anesthesiology-Critical Care Medicine, and Neurosurgery (R.G.G.), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Neurology (E.W., A.R.), Mayo Clinic, Rochester, MN; Department of Neurology (M.J.A.), University of Florida-McKnight Brain Institute, Gainesville; Department of Neurology and Neurocritical Care Unit (M.D.), Cambridge University Hospitals; The Ipswich Hospital (M.D.), Cambridge, UK; Departments of Neurology and Neurosurgery (S.A.M.), Mount Sinai-Icahn School of Medicine, New York, NY; Departments of Emergency Medicine and Internal Medicine (Cardiology) (J.P.O.), Virginia Commonwealth University College of Medicine, Richmond; Department of Neurology (J.I.S.), Baylor College of Medicine, Houston, TX; Department of Neurology and Neurosurgery (M.T.T.), Ohio State University, Columbus; Department of Neurology (R.M.D.), Kansas University Medical Center, Kansas City; and Department of Neurology (J.L.), University of Toronto, Canada.
Abstract
OBJECTIVE: To assess the evidence and make evidence-based recommendations for acute interventions to reduce brain injury in adult patients who are comatose after successful cardiopulmonary resuscitation. METHODS: Published literature from 1966 to August 29, 2016, was reviewed with evidence-based classification of relevant articles. RESULTS AND RECOMMENDATIONS: For patients who are comatose in whom the initial cardiac rhythm is either pulseless ventricular tachycardia (VT) or ventricular fibrillation (VF) after out-of-hospital cardiac arrest (OHCA), therapeutic hypothermia (TH; 32-34°C for 24 hours) is highly likely to be effective in improving functional neurologic outcome and survival compared with non-TH and should be offered (Level A). For patients who are comatose in whom the initial cardiac rhythm is either VT/VF or asystole/pulseless electrical activity (PEA) after OHCA, targeted temperature management (36°C for 24 hours, followed by 8 hours of rewarming to 37°C, and temperature maintenance below 37.5°C until 72 hours) is likely as effective as TH and is an acceptable alternative (Level B). For patients who are comatose with an initial rhythm of PEA/asystole, TH possibly improves survival and functional neurologic outcome at discharge vs standard care and may be offered (Level C). Prehospital cooling as an adjunct to TH is highly likely to be ineffective in further improving neurologic outcome and survival and should not be offered (Level A). Other pharmacologic and nonpharmacologic strategies (applied with or without concomitant TH) are also reviewed.
OBJECTIVE: To assess the evidence and make evidence-based recommendations for acute interventions to reduce brain injury in adult patients who are comatose after successful cardiopulmonary resuscitation. METHODS: Published literature from 1966 to August 29, 2016, was reviewed with evidence-based classification of relevant articles. RESULTS AND RECOMMENDATIONS: For patients who are comatose in whom the initial cardiac rhythm is either pulseless ventricular tachycardia (VT) or ventricular fibrillation (VF) after out-of-hospital cardiac arrest (OHCA), therapeutic hypothermia (TH; 32-34°C for 24 hours) is highly likely to be effective in improving functional neurologic outcome and survival compared with non-TH and should be offered (Level A). For patients who are comatose in whom the initial cardiac rhythm is either VT/VF or asystole/pulseless electrical activity (PEA) after OHCA, targeted temperature management (36°C for 24 hours, followed by 8 hours of rewarming to 37°C, and temperature maintenance below 37.5°C until 72 hours) is likely as effective as TH and is an acceptable alternative (Level B). For patients who are comatose with an initial rhythm of PEA/asystole, TH possibly improves survival and functional neurologic outcome at discharge vs standard care and may be offered (Level C). Prehospital cooling as an adjunct to TH is highly likely to be ineffective in further improving neurologic outcome and survival and should not be offered (Level A). Other pharmacologic and nonpharmacologic strategies (applied with or without concomitant TH) are also reviewed.
Authors: Robert W Neumar; Jerry P Nolan; Christophe Adrie; Mayuki Aibiki; Robert A Berg; Bernd W Böttiger; Clifton Callaway; Robert S B Clark; Romergryko G Geocadin; Edward C Jauch; Karl B Kern; Ivan Laurent; W T Longstreth; Raina M Merchant; Peter Morley; Laurie J Morrison; Vinay Nadkarni; Mary Ann Peberdy; Emanuel P Rivers; Antonio Rodriguez-Nunez; Frank W Sellke; Christian Spaulding; Kjetil Sunde; Terry Vanden Hoek Journal: Circulation Date: 2008-10-23 Impact factor: 29.690
Authors: Maaret Castrén; Per Nordberg; Leif Svensson; Fabio Taccone; Jean-Louise Vincent; Didier Desruelles; Frank Eichwede; Pierre Mols; Tilmann Schwab; Michel Vergnion; Christian Storm; Antonio Pesenti; Jan Pachl; Fabien Guérisse; Thomas Elste; Markus Roessler; Harald Fritz; Pieterjan Durnez; Hans-Jörg Busch; Becky Inderbitzen; Denise Barbut Journal: Circulation Date: 2010-08-02 Impact factor: 29.690
Authors: Ruut Laitio; Marja Hynninen; Olli Arola; Sami Virtanen; Riitta Parkkola; Jani Saunavaara; Risto O Roine; Juha Grönlund; Emmi Ylikoski; Johanna Wennervirta; Minna Bäcklund; Päivi Silvasti; Eija Nukarinen; Marjaana Tiainen; Antti Saraste; Mikko Pietilä; Juhani Airaksinen; Leena Valanne; Juha Martola; Heli Silvennoinen; Harry Scheinin; Veli-Pekka Harjola; Jussi Niiranen; Kirsi Korpi; Marjut Varpula; Outi Inkinen; Klaus T Olkkola; Mervyn Maze; Tero Vahlberg; Timo Laitio Journal: JAMA Date: 2016-03-15 Impact factor: 56.272
Authors: Johann Reisinger; Kurt Höllinger; Wolfgang Lang; Christoph Steiner; Thomas Winter; Andreas Winter; Michael Mori; Alexander Lindorfer; Daniel Kiblböck; Peter Siostrzonek Journal: Am J Emerg Med Date: 2009-02 Impact factor: 2.469
Authors: Francis Kim; Graham Nichol; Charles Maynard; Al Hallstrom; Peter J Kudenchuk; Thomas Rea; Michael K Copass; David Carlbom; Steven Deem; W T Longstreth; Michele Olsufka; Leonard A Cobb Journal: JAMA Date: 2014-01-01 Impact factor: 56.272
Authors: Annelise M Kulpanowski; William A Copen; Brandon L Hancock; Eric S Rosenthal; David A Schoenfeld; Jacob A Dodelson; Brian L Edlow; W Taylor Kimberly; Edilberto Amorim; M Brandon Westover; Ming Ming Ning; Pamela W Schaefer; Rajeev Malhotra; Joseph T Giacino; David M Greer; Ona Wu Journal: Resuscitation Date: 2022-02-08 Impact factor: 6.251
Authors: Krishma Adatia; Romergryko G Geocadin; Ryan Healy; Wendy Ziai; Luciano Ponce-Mejia; Mirinda Anderson-White; Dhaval Shah; Batya R Radzik; Caitlin Palmisano; Charles W Hogue; Charles Brown; Lucia Rivera-Lara Journal: Crit Care Med Date: 2018-08 Impact factor: 7.598